Bronchiolite obliterante post-infettiva (PIBO), chi è costei?

Q4 Medicine Medico e Bambino Pub Date : 2024-05-24 DOI:10.53126/meb43317
Arianna Traunero, Simona Basilicata, L. Badina, M. Maschio, S. Ghirardo, A. Amaddeo
{"title":"Bronchiolite obliterante post-infettiva (PIBO), chi è costei?","authors":"Arianna Traunero, Simona Basilicata, L. Badina, M. Maschio, S. Ghirardo, A. Amaddeo","doi":"10.53126/meb43317","DOIUrl":null,"url":null,"abstract":"The paper presents the case of a 14-month-old child with a persistent respiratory distress with wheezing and diffuse crackles on chest auscultation. Symptoms appeared after a viral pneumonia caused by Adenovirus. The recent history, the clinical manifestations and the lung CT (Computed Tomography) scans, which showed a diffuse mosaic pattern, with air trapping, bronchiectasis and peribronchial inflammation, led to the diagnosis of Post-infectious Bronchiolitis Obliterans (PIBO). PIBO is a rare chronic paediatric pulmonary disease characterized by irreversible fibrotic narrowing of the small airways. It can present with a broad severity spectrum, and the evolution of this condition is not predictable in the single patient. Adenovirus is by far the most common cause of this lung pathology, and during the post Covid-19 pandemic an unprecedented rise in PIBO cases triggered by Adenovirus lower respiratory infections was observed. The treatment of PIBO is empirical, and a defined protocol does not exist yet. Therapeutic approaches range from nil to methylprednisolone pulse therapy, which would seem effective especially if performed early and if peribronchitis is found on imaging. Some studies evaluated the administration of intravenous immunoglobulins, while in more advanced cases showing fibrotic transformation of the parenchyma, the use of antifibrotic drugs (hydroxychloroquine, nintedanib) may be tried","PeriodicalId":39695,"journal":{"name":"Medico e Bambino","volume":"10 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medico e Bambino","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53126/meb43317","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

The paper presents the case of a 14-month-old child with a persistent respiratory distress with wheezing and diffuse crackles on chest auscultation. Symptoms appeared after a viral pneumonia caused by Adenovirus. The recent history, the clinical manifestations and the lung CT (Computed Tomography) scans, which showed a diffuse mosaic pattern, with air trapping, bronchiectasis and peribronchial inflammation, led to the diagnosis of Post-infectious Bronchiolitis Obliterans (PIBO). PIBO is a rare chronic paediatric pulmonary disease characterized by irreversible fibrotic narrowing of the small airways. It can present with a broad severity spectrum, and the evolution of this condition is not predictable in the single patient. Adenovirus is by far the most common cause of this lung pathology, and during the post Covid-19 pandemic an unprecedented rise in PIBO cases triggered by Adenovirus lower respiratory infections was observed. The treatment of PIBO is empirical, and a defined protocol does not exist yet. Therapeutic approaches range from nil to methylprednisolone pulse therapy, which would seem effective especially if performed early and if peribronchitis is found on imaging. Some studies evaluated the administration of intravenous immunoglobulins, while in more advanced cases showing fibrotic transformation of the parenchyma, the use of antifibrotic drugs (hydroxychloroquine, nintedanib) may be tried
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
感染后阻塞性支气管炎 (PIBO),谁是它的患者?
本文介绍了一例 14 个月大的患儿的病例,该患儿患有持续性呼吸困难,胸部听诊时伴有喘息和弥漫性噼啪声。症状出现于由腺病毒引起的病毒性肺炎之后。根据近期病史、临床表现和肺部 CT(计算机断层扫描)扫描(显示弥漫性马赛克模式,伴有空气潴留、支气管扩张和支气管周围炎症),诊断为感染后支气管炎闭塞症(PIBO)。PIBO 是一种罕见的慢性儿科肺病,其特点是小气道不可逆转的纤维化狭窄。这种疾病的严重程度不一,而且无法预测单个患者的病情发展。迄今为止,腺病毒是导致这种肺部病变的最常见原因,在科维德-19 大流行后,由腺病毒下呼吸道感染引发的 PIBO 病例出现了前所未有的增长。PIBO 的治疗是经验性的,目前还没有明确的方案。治疗方法从无到甲基强的松龙脉冲疗法不等,尤其是在早期和影像学检查发现支气管周围炎的情况下,脉冲疗法似乎更为有效。一些研究对静脉注射免疫球蛋白进行了评估,而对于出现肺实质纤维化转变的晚期病例,可尝试使用抗纤维化药物(羟氯喹、宁替丹尼)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Medico e Bambino
Medico e Bambino Medicine-Pediatrics, Perinatology and Child Health
CiteScore
0.50
自引率
0.00%
发文量
128
期刊最新文献
L’occhio (non) fa sempre la differenza: quando il sospetto clinico guida per mano la diagnosi Prescrizione di antibiotici in Pronto Soccorso pediatrico Le vite salvate dai vaccini negli ultimi 50 anni Cosa deve sapere oggi il pediatra del trattamento dell’epatite C nell’era dei nuovi farmaci antivirali? L’otite esterna acuta: dalla diagnosi al trattamento
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1